Breaking News Instant updates and real-time market news.

TEVA

Teva

$37.93

0.0722 (0.19%)

10:29
11/30/16
11/30
10:29
11/30/16
10:29

Teva weekly calls are active

Teva weekly calls are active. The stock is up 27c to $38.13 and saw a small morning spike amid takeover chatter. 1.6K Dec 2nd 38.5 calls have changed hands. Dec 2nd 38 and 39 calls are the next most active in TEVA. Total volume is 6.2K calls and 1.5K puts. More than two-thirds of the activity is in Weekly options that expire in a couple of days.

  • 30

    Nov

TEVA Teva
$37.93

0.0722 (0.19%)

11/16/16
11/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Sysco (SYY) downgraded to Neutral from Outperform at Credit Suisse with analyst Edward Kelly saying Sysco shares are up 50% over the last 18 months and now views risk/reward as balanced. 2. Teva (TEVA) downgraded to Hold from Buy at Jefferies, to Equal Weight from Overweight at Morgan Stanley, and to Neutral from Buy at BTIG. 3. Bank of America (BAC) Capital One (COF) downgraded to Neutral from Outperform at Baird while the firm downgraded Fifth Third (FITB) to Underperform from Neutral. 4. Zions Bancorp (ZION) downgraded to Equal Weight from Overweight at Morgan Stanley and to Market Perform from Outperform at Bernstein. 5. Yingli Green Energy (YGE) downgraded to Sell from Buy at Axiom while the firm downgraded SolarCity (SCTY) and JA Solar (JASO) to Sell from Hold. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/17/16
MAXM
11/17/16
NO CHANGE
Target $52
MAXM
Buy
Teva price target lowered to $52 from $72 at Maxim
Maxim analyst Gabrielle Zhou lowered her price target for Teva to $52 from $72 after the company reported Q3 results and cut it full-year guidance. The analyst notes that the company has started its Actavis integration, with the latter now contributing to Teva's generic revenues. However, she believes Teva needs to focus now on growth, noting that 2017 will be a challenge. Zhou reiterates a Buy rating on Teva's shares.
11/22/16
LEER
11/22/16
NO CHANGE
LEER
Outperform
Alder Biopharmaceuticals patent fight far from over, says Leerink
Leerink analyst Joseph Schwartz says Alder Biopharmaceuticals (ALDR) stated that the European Patent Office issued a ruling revoking all claims in its competitor Teva's (TEVA) patent relating to CGRP antagonist antibodies but maintaining and narrowing claims relating to the use of CGRP antagonist antibodies in human therapy to the prevention or treatment of headache such as migraine and cluster headache. The analyst notes that the persistence of the headache claims has concerned investors, but points out that Alder believes the patent fight is far from over in the EU, or moreover in the U.S. Schwartz reiterates an Outperform rating on Alder's shares.
11/25/16
PIPR
11/25/16
NO CHANGE
Target $47
PIPR
Overweight
Alder recent selloff an overreaction, says Piper Jaffray
Piper Jaffray analyst Charles Duncan attributes the recent weakness in shares of Alder Biopharmaceuticals (ALDR) to "increased visibility and outcome uncertainty" for the company's challenge to Teva's (TEVA) anti-CGRP patents in the U.S. and Europe. The analyst views the selloff as an overreaction and remains focused on his "clinical data-driven thesis for the emerging, differentiated profile of lead candidate ALD403." Duncan keeps an Overweight rating on Alder with a $47 price target.

TODAY'S FREE FLY STORIES

MRSN

Mersana Therapeutics

21:10
06/27/17
06/27
21:10
06/27/17
21:10
Syndicate
Mersana Therapeutics 5M share IPO priced at $15.00 »

The deal priced in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

BLUE

bluebird bio

$106.90

-4.2 (-3.78%)

21:09
06/27/17
06/27
21:09
06/27/17
21:09
Syndicate
bluebird bio 3.81M share Secondary priced at $105.00 »

Goldman Sachs,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

ADNT

Adient

$63.20

-1.63 (-2.51%)

20:25
06/27/17
06/27
20:25
06/27/17
20:25
Conference/Events
Adient to hold a meeting »

EVP & CFO Stafeil,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jul

GIS

General Mills

$55.52

-0.65 (-1.16%)

, MON

Monsanto

$117.25

-0.55 (-0.47%)

20:25
06/27/17
06/27
20:25
06/27/17
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

GIS

General Mills

$55.52

-0.65 (-1.16%)

MON

Monsanto

$117.25

-0.55 (-0.47%)

PAYX

Paychex

$58.62

-0.62 (-1.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 28

    Jun

  • 12

    Jul

AAPL

Apple

$143.73

-2.09 (-1.43%)

19:32
06/27/17
06/27
19:32
06/27/17
19:32
Periodicals
Apple looks to hire 'Siri Event Maven,' 9to5Mac reports »

An Apple job listing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOSBF

Toshiba, also use TOSYY

$2.60

-0.09 (-3.35%)

, TOSYY

Toshiba, also use TOSBF

$15.67

-0.24 (-1.51%)

19:22
06/27/17
06/27
19:22
06/27/17
19:22
Periodicals
Toshiba to face holder wrath after failing to sell chip unit, Reuters says »

Toshiba is anticipated to…

TOSBF

Toshiba, also use TOSYY

$2.60

-0.09 (-3.35%)

TOSYY

Toshiba, also use TOSBF

$15.67

-0.24 (-1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$150.58

-3.01 (-1.96%)

19:21
06/27/17
06/27
19:21
06/27/17
19:21
Periodicals
Facebook previously explored effort to promote flu shots, CNBC reports »

Facebook was working with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

AAPL

Apple

$143.73

-2.09 (-1.43%)

19:15
06/27/17
06/27
19:15
06/27/17
19:15
Hot Stocks
Munster lays out five-year Apple model, sees 'Apple Glasses' wearable in 2020 »

Gene Munster, a longtime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

, GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

19:02
06/27/17
06/27
19:02
06/27/17
19:02
Hot Stocks
Senator urges FTC oversight of Google in wake of Europe fine »

Senator Richard…

GOOG

Alphabet

$927.33

-24.94 (-2.62%)

GOOGL

Alphabet Class A

$948.09

-24 (-2.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

APO

Apollo Global

$25.90

-0.33 (-1.26%)

18:58
06/27/17
06/27
18:58
06/27/17
18:58
Periodicals
Apollo Global hits record-breaking $23.5B target for buyout fund, WSJ says »

Private equity firm…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$55.43

-1.13 (-2.00%)

18:54
06/27/17
06/27
18:54
06/27/17
18:54
Periodicals
Judge says FTC suit against Qualcomm can proceed, Reuters reports »

A federal judge ruled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNEGY

Linde

$19.25

0.08 (0.42%)

18:53
06/27/17
06/27
18:53
06/27/17
18:53
Periodicals
Linde unit agrees to $20M settlement deal in whistleblower case, Reuters says »

Linde's Lincare…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCHC

HC2 Holdings

$5.82

0.03 (0.52%)

18:50
06/27/17
06/27
18:50
06/27/17
18:50
Hot Stocks
HC2 Holdings subsidiary to acquire major interest in DTVA »

HC2 Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$65.54

-0.38 (-0.58%)

18:38
06/27/17
06/27
18:38
06/27/17
18:38
Periodicals
Merck's cholesterol drug anacetrapib could serve as catalyst, Barron's reports »

Merck announced results…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

TROX

Tronox

$13.52

-0.25 (-1.82%)

18:37
06/27/17
06/27
18:37
06/27/17
18:37
Hot Stocks
Tronox elects Kaufthal as non-executive chairman »

Tronox announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANCUF

Alimentation Couche-Tard

$49.16

1.0803 (2.25%)

, CST

CST Brands

$48.53

-0.01 (-0.02%)

18:19
06/27/17
06/27
18:19
06/27/17
18:19
Hot Stocks
Alimentation Couche-Tard cleared in Canada for acquisition of CST Brands »

Alimentation Couche-Tard…

ANCUF

Alimentation Couche-Tard

$49.16

1.0803 (2.25%)

CST

CST Brands

$48.53

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSLI

Merus Labs

$1.23

-0.0015 (-0.12%)

18:01
06/27/17
06/27
18:01
06/27/17
18:01
Hot Stocks
Merus Labs reminds shareholders to vote for arrangement with Norgine »

Merus Labs International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIGI

Endurance

$8.20

-0.15 (-1.80%)

18:01
06/27/17
06/27
18:01
06/27/17
18:01
Hot Stocks
Endurance chief administration officer Andreasen to leave company »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HII

Huntington Ingalls

$186.97

0.68 (0.37%)

17:41
06/27/17
06/27
17:41
06/27/17
17:41
Hot Stocks
Huntington Ingalls receives contract modifications to incorporate upgrades »

Huntington Ingalls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IP

International Paper

$56.18

-0.55 (-0.97%)

17:34
06/27/17
06/27
17:34
06/27/17
17:34
Hot Stocks
International Paper agrees to settle Kleen Products class action litigation »

International Paper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUSA

Houston American Energy

$0.67

0.0385 (6.10%)

17:33
06/27/17
06/27
17:33
06/27/17
17:33
Syndicate
Houston American Energy requests withdrawal of registration statement »

The company determined…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$22.82

0.04 (0.18%)

, RYI

Ryerson

$9.00

-0.1 (-1.10%)

17:24
06/27/17
06/27
17:24
06/27/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: KB…

KBH

KB Home

$22.82

0.04 (0.18%)

RYI

Ryerson

$9.00

-0.1 (-1.10%)

AVAV

AeroVironment

$32.49

1.52 (4.91%)

CAMP

CalAmp

$19.25

-0.37 (-1.89%)

GMRE

Global Medical REIT

$9.83

0.07 (0.72%)

WLL

Whiting Petroleum

$5.48

0.04 (0.74%)

OAS

Oasis Petroleum

$7.93

0.21 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 03

    Jul

  • 04

    Jul

  • 05

    Jul

  • 28

    Jun

CHKE

Cherokee

17:22
06/27/17
06/27
17:22
06/27/17
17:22
Hot Stocks
Breaking Hot Stocks news story on Cherokee »

Cherokee says announcing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 18

    Jul

KBH

KB Home

$22.82

0.04 (0.18%)

17:16
06/27/17
06/27
17:16
06/27/17
17:16
Hot Stocks
KB Home sees Q3 housing revenue $1.08B-$1.15B »

Sees Q3 average selling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

KBH

KB Home

$22.82

0.04 (0.18%)

17:16
06/27/17
06/27
17:16
06/27/17
17:16
Hot Stocks
KB Home raises FY17 housing revenue view to $4.2B-$4.4B from $4B-$4.3B »

Sees FY17 average selling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.